http://www.eurosciconnews.com/blog Euroscicon host unbiased events where scientists from many fields can participate and offer their own experiences of technology that can help improve the experiments of others. Each event is an opportunity for industry and academia to share discussion, new bonds and new ideas for the future. This site is a listing of news from Euroscicon plus information from our partners and friends. It contains current information on selected events, details of our prize draw winners, press releases about new reagents and technologies, job offers and information on occasional discounted registrations. en-us Wed, 01 Jul 2009 14:08:27 +0100 Main Page Blogware Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/7/1/4241469.html http://www.eurosciconnews.com/blog/_archives/2009/7/1/4241469.html Wed, 01 Jul 2009 14:08:04 +0100 We are pleased to announce that a report from our Nanotoxicology meeting, which took place in February of this year, has been published in Nanomedicine Main Page nanotoxicology Health environment sharac http://www.eurosciconnews.com/blog/_archives/2009/6/20/3841116.html http://www.eurosciconnews.com/blog/_archives/2009/6/20/3841116.html Sat, 20 Jun 2009 10:00:00 +0100 Food Processing pursues the issues that impact the product development and production teams the most, notably; new product development, removing costs from the process and critical issues. Main Page Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/6/19/4226972.html http://www.eurosciconnews.com/blog/_archives/2009/6/19/4226972.html Fri, 19 Jun 2009 10:48:18 +0100 We are pleased to announce that a report from our meeting 'Improving Immunohistochemistry' has been published in The Biomedical Scientist. Main Page improving immunohistochemistry sharac http://www.eurosciconnews.com/blog/_archives/2009/6/18/4226360.html http://www.eurosciconnews.com/blog/_archives/2009/6/18/4226360.html Thu, 18 Jun 2009 19:57:56 +0100 Scientists in the Departments of Medicine and Molecular Genetics at the Albert Einstein College of Medicine are isolating proteins from the serum of Ashkenazi Jewish centenarians, their offspring and age-matched offspring controls. The proteins are extracted and then run on 1D gels stained with Coomassie blue and are also transferred onto Western blots, probed with different antibodies and then stained with Horse Radish Peroxidase. The 1D protein gels and Western blots produced are imaged and analysed using a Dyversity system, enabling researchers to detect specific proteins and establish if these are connected with a longer life. Main Page Dyversity Einstein Ashkenazi Jewish Albert College centenarians system sharac http://www.eurosciconnews.com/blog/_archives/2009/6/16/4223823.html http://www.eurosciconnews.com/blog/_archives/2009/6/16/4223823.html Tue, 16 Jun 2009 11:12:56 +0100 A breakthrough in image understanding and quantitation that extracts information from images of stained tissue sections Main Page color images staining IHC multispectral Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/6/15/4206752.html http://www.eurosciconnews.com/blog/_archives/2009/6/15/4206752.html Mon, 15 Jun 2009 08:00:00 +0100 The chair for this meeting will be Dr David Whitehouse. The agenda is under construction. If you have any queries or are interested in speaking at this event please contact meetingsproducer@euroscicon.com. The meeting has CPD approval. Main Page spermatozoa parasitology microdissection laser EurosciconWebmaster http://www.eurosciconnews.com/blog/_archives/2009/6/10/3840531.html http://www.eurosciconnews.com/blog/_archives/2009/6/10/3840531.html Wed, 10 Jun 2009 13:00:00 +0100 This site has been designed specifically for PhD students and for those thinking about doing a PhD Main Page Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/6/8/4206713.html http://www.eurosciconnews.com/blog/_archives/2009/6/8/4206713.html Mon, 08 Jun 2009 08:00:00 +0100 We are pleased to announce this follow up meeting to our 2008 'Molecular farming- plant biologicals' event. The meeting chair is Professor Julian K-C. Ma, Hotung (Chair of Molecular Immunology, St. George's, University of London) and the meeting will have CPD approval. Main Page recombinant plant pharmaceutical molecular farming Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/6/1/4202589.html http://www.eurosciconnews.com/blog/_archives/2009/6/1/4202589.html Mon, 01 Jun 2009 09:00:00 +0100 We are pleased to announce this follow up meeting to our successful Developments in Cell Culture Technology to enhance Cell Growth In Vitro meeting. The chair will be Dr Stefan Przyborski and the meeting has CPD approval. Main Page technology culture cell advances Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/5/22/4194728.html http://www.eurosciconnews.com/blog/_archives/2009/5/22/4194728.html Fri, 22 May 2009 12:16:32 +0100 "Huge technological advances have been made recently in the genomic and post-genomic analyses of pathogens and disease. To exploit these advances for the production of successful recombinant vaccines we need strategies to select appropriate molecules and to deliver them appropriately to stimulate protective immune responses. This meeting will explore both candidate discovery and the tools for delivering vaccines effectively". Meeting Chair: Dr Alasdair Nisbet, Moredun Research Institute, UK. The meeting has CPD approval. Main Page GM mucosal vaccines recombinant sharac http://www.eurosciconnews.com/blog/_archives/2009/5/20/3841109.html http://www.eurosciconnews.com/blog/_archives/2009/5/20/3841109.html Wed, 20 May 2009 09:00:00 +0100 Feed International is a business journal for people involved in the feed industry internationally. Main Page Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/5/15/4170582.html http://www.eurosciconnews.com/blog/_archives/2009/5/15/4170582.html Fri, 15 May 2009 10:00:00 +0100 "This meeting will provide an update on phenotypic and functional aspects of regulatory T cells, aiming to inform, educate and entertain. Presentations will be delivered by world-class leaders in their respective fields and a lively discussion will follow each series of talks. Coupled with the pleasant ambience and modern facilities of the venue, this event promises to be one not to be missed" Meeting Chair: Dr Oliver Garden,The Royal Veterinary College & Imperial College London, UK. The meeting has CPD approval. Main Page cells t autoimmunity regulatory cancer sharac http://www.eurosciconnews.com/blog/_archives/2009/5/12/4183744.html http://www.eurosciconnews.com/blog/_archives/2009/5/12/4183744.html Tue, 12 May 2009 17:28:03 +0100 Asterand plc (LSE: ATD), a leading provider of human tissue and services to scientists engaged in drug discovery research, announces that it has entered into a collaborative agreement with Abcam plc (AIM: ABC), the rapidly growing bioscience company that markets antibodies via its own online catalogue. Asterand will undertake the validation and characterisation of a selected group of Abcam antibodies for immuno-histochemistry applications using Asterand’s PhaseZERO® Human Tissue Services platform. Main Page sharac http://www.eurosciconnews.com/blog/_archives/2009/5/10/3843464.html http://www.eurosciconnews.com/blog/_archives/2009/5/10/3843464.html Sun, 10 May 2009 13:00:00 +0100 It's so difficult to know what to get a colleague at the special time in their lives. Main Page Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/5/8/4170517.html http://www.eurosciconnews.com/blog/_archives/2009/5/8/4170517.html Fri, 08 May 2009 11:00:00 +0100 The agenda for this event is under construction. If you have any queries or are interested in speaking at this event please contact meetingsproducer@euroscicon.com. The meeting has CPD approval Main Page peptides antimicrobial Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/5/1/4168426.html http://www.eurosciconnews.com/blog/_archives/2009/5/1/4168426.html Fri, 01 May 2009 10:25:39 +0100 "Once you can produce it in a flask, what next? The focus of this meeting will be on techniques for the bioproduction of usable quantities of biologic materials, specifically recombinant proteins, monoclonal antibodies, cytokines viruses and other secreted cellular products from eukaryotic cells. Topics covered will include expression systems, mammalian vs. insect vs. other, constituitive vs. transient expression, cell culture medium considerations and culture devices for scale-up that can be used in any laboratory. This meeting should show the fastest pathway from discovery to proof of principle and the production of 100 mgs to several grams of product" Meeting Chair: Dr John J.S. Cadwell, President and CEO, FiberCell Systems Inc, USA. The meeting has CPD approval. Main Page virus small scale recombinant proteins monoclonal cytokines bioproduction antibodies Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/4/29/4168290.html http://www.eurosciconnews.com/blog/_archives/2009/4/29/4168290.html Wed, 29 Apr 2009 15:48:29 +0100 Four clearly distinct, focused sessions are planned.. Session A will cover different applications of ELISPOT that are unique to the technique and should be of general interest because it can be applied to all fields of study in which ELISPOT is used. Session B will be dedicated to ELISPOT standardization, harmonization and validation. There are three major multicenter programs ongoing and these will provide a briefing on the progress they have made. Sessions C and D are assigned to the ELISPOT reagent and instrument manufacturers to share new developments on their front. Session E is dedicated to questions and answer. Participants will be asked to submit questions before the meeting, and also to ask questions ad hoc – these questions will be discussed. The meeting has CPD approval. Main Page multiplexing applications validation standardization ELISPOT sharac http://www.eurosciconnews.com/blog/_archives/2009/4/29/4167114.html http://www.eurosciconnews.com/blog/_archives/2009/4/29/4167114.html Wed, 29 Apr 2009 15:00:00 +0100 Are you measuring or want to measure cytokines ? , trying to optimise your technique or do you want just to make sure you are going about it the right way? This meeting aims to summarise some of the options open to you and to discuss which techniques best suit your requirements. A series of presentations from experts working in the academic, clinical and commercial sectors will compare recent developments in technologies ranging from relatively “low-tech” assays such as ELISA, Elispot and bioassays through to the “high-tech” platform technologies of various multiplex cytokine detection systems. Their use in basic science, R&D and translational research will be discussed Main Page sharac http://www.eurosciconnews.com/blog/_archives/2009/4/28/4167087.html http://www.eurosciconnews.com/blog/_archives/2009/4/28/4167087.html Tue, 28 Apr 2009 15:08:29 +0100 The Deadline for abstract submissions for oral presentation is June 10th 2009 Abstracts for poster presentation only can be submitted up to two weeks before the event Main Page Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/4/27/4165945.html http://www.eurosciconnews.com/blog/_archives/2009/4/27/4165945.html Mon, 27 Apr 2009 11:56:38 +0100 "Significant advances in our understanding of the innate immune recognition have been made in the last decade following the identification of three families of pattern recognition receptors: Toll-like receptors (TLRs), NOD-like receptors (NLRs) and RIG-I-like receptors (RLRs). TLRs are pattern recognition receptors that detect motifs or signatures from bacteria, viruses, protozoa and fungi. NLRs detect mainly intracellular bacteria and RLRs detect viral genome. These three families of pattern recognition receptors comprise the front line of defence that the host possesses against microbial pathogens. The aim of this meeting is to provide an overview of these three families of receptors and provide the most recent advances in the area of innate immune pattern recognition". Chairs: Dr Martha Triantafilou/Dr Kathy Triantafilou, University of Sussex, UK Main Page NLR receptor receptors RIG nod toll like TLR protein sharac http://www.eurosciconnews.com/blog/_archives/2009/4/20/3841084.html http://www.eurosciconnews.com/blog/_archives/2009/4/20/3841084.html Mon, 20 Apr 2009 10:00:00 +0100 FierceBioResearcher is an easy to read weekly source of biotech research news, information and tools, with a special focus on science of drug discovery and development. Main Page sharac http://www.eurosciconnews.com/blog/_archives/2009/4/16/4154667.html http://www.eurosciconnews.com/blog/_archives/2009/4/16/4154667.html Thu, 16 Apr 2009 08:28:16 +0100 LGC Standards has opened its first office in Beijing, China, signalling a milestone in the company’s international development. The new office will enable the company to bring its range of laboratory quality products and services to the Chinese market. Main Page sharac http://www.eurosciconnews.com/blog/_archives/2009/4/10/3843451.html http://www.eurosciconnews.com/blog/_archives/2009/4/10/3843451.html Fri, 10 Apr 2009 13:00:00 +0100 The Single Scientist is an international site for scientists to browse and network, Main Page Single scientist Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/3/27/4135342.html http://www.eurosciconnews.com/blog/_archives/2009/3/27/4135342.html Fri, 27 Mar 2009 11:53:14 +0000 The chair of our meeting on 19th June this year, will be Dr Richard Williams from Imperial College. Our exciting agenda includes many well renowned speakers... Main Page sclerosis rheumatoid multiple lupus human Disease autoimmunity Autoimmune arthritis Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/3/25/4131682.html http://www.eurosciconnews.com/blog/_archives/2009/3/25/4131682.html Wed, 25 Mar 2009 08:00:00 +0000 This meeting will explore the new technological advances and research currently being undertaken to irradicate these neglected diseases and discuss the greater implications these will have to global public health". Meeting Chair: Professor P.K. Das, University of Amsterdam, The Netherlands . The meeting has CPD approval. THE FEE FOR THIS MEETING HAS BEEN REDUCED BY 30% (if you have not already registered). Main Page tropical schistosomiasis public NK MHC malaria leprosy Health Disease Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/3/23/4130926.html http://www.eurosciconnews.com/blog/_archives/2009/3/23/4130926.html Mon, 23 Mar 2009 16:55:27 +0000 We are pleased to announce that a report from our meeting ‘Flow cytometry: recent advances in techniques and instrumentation’ has been published in The Biomedical Scientist. Main Page flow techniques instrumentation cytometry sharac http://www.eurosciconnews.com/blog/_archives/2009/3/20/3841079.html http://www.eurosciconnews.com/blog/_archives/2009/3/20/3841079.html Fri, 20 Mar 2009 19:00:00 +0000 Nature Biotechnology devotes pages specifically to in-depth analysis of issues concerning biotechnology intellectual property case law and policy, together with breaking news on patents. Main Page Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/3/20/4125516.html http://www.eurosciconnews.com/blog/_archives/2009/3/20/4125516.html Fri, 20 Mar 2009 08:00:00 +0000 The Ontario Genomics Institute (OGI) has invested in a London, Ontario start-up company, Cytognomix, to enable the commercial development of novel cytogenetic DNA probes that detect and pinpoint anomalies in the genome at higher resolution than is currently routinely possible.. Main Page DNA probe Single cell Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/3/13/4116904.html http://www.eurosciconnews.com/blog/_archives/2009/3/13/4116904.html Tue, 17 Mar 2009 09:00:00 +0000 Agilent Technologies Inc. has announced the introduction of its SurePrint G3 Microarrays.... Main Page third sureprint quadrupling probe microarrays generation g3 density Agilent Dr Astrid Englezou http://www.eurosciconnews.com/blog/_archives/2009/3/11/4118054.html http://www.eurosciconnews.com/blog/_archives/2009/3/11/4118054.html Fri, 13 Mar 2009 12:00:00 +0000 This popular annual event, now in its 6th year, is dedicated to the technique of immunohistochemistry and in situ hybridisation.“This exciting meeting has been created to merge the need for technical-based updates in the areas of immunohistochemistry, clinical histopathology and in situ hybridisation. Academic speakers from each area of research will give technical presentationsof 30 minute duration interspersed with 15 minute scientific contributions from commercial speakers”. Meeting Chair: Dr Will Howat, Cambridge Research Institute, Cancer Research UK. The meeting has CPD approval. Main Page immunofluorescence histopathology pathgrid immunohistochemistry fluorescence fish